secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001628280-25-037426
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Sell resigns; agilon posts $104M Q2 net loss, suspends 2025 guidance
------------------------------------------------------------------------

- Steven Sell resigned as CEO/President and Board director effective July 29; Board reduced to seven directors.
- Executive Chairman Ron Williams appointed; Office of the Chairman formed to oversee interim operations.
- Q2 total revenue $1.39B (-6% YoY); net loss $104M vs $31M loss in Q2 2024.
- Medical margin negative $53M vs positive $106M; adjusted EBITDA loss $83M vs $3M loss.
- Full-year 2025 guidance suspended due to leadership change and market headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/0001628280-25-037426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/agl-20250729.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer